Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 7 clinical trials
featured
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.

sleep disorder
cataplexy
somnolence
sodium oxybate
stimulant
  • 86 views
  • 10 Jul, 2018
  • 53 locations
featured
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy

The purpose of this study is to determine whether Sodium Oxybate is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.  

sodium oxybate
cataplexy
excessive daytime sleepiness
stimulant
  • 217 views
  • 22 Feb, 2019
  • 1 location
featured
Fibromyalgia

Fibromyalgia

  • 7030 views
  • 08 Nov, 2020
  • 1 location
Sodium Oxybate in Idiopathic Hypersomnia

this study evaluates of the efficacy of sodium oxybate on excessive daytime sleepiness using Epworth sleepiness scale over 8 weeks compared to placebo

polysomnography
sodium oxybate oral solution
xyrem
sleepiness
multiple sleep latency test
  • 45 views
  • 19 Feb, 2021
  • 1 location
Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate

This study is the first clinical trial using sodium oxybate for the treatment of REM sleep behavior disorder (RBD). Sodium oxybate is a drug approved by FDA for the treatment of narcolepsy which

parkinson's disease
narcolepsy
  • 14 views
  • 07 Jul, 2021
  • 1 location
Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor

Using a comprehensive approach of clinico-behavioral testing, neuroimaging and pharmacogenetics, the researchers will examine the clinical effects of sodium oxybate and the matched placebo on

  • 776 views
  • 18 Jul, 2021
  • 1 location
An Open Label Study of FT218 in Subjects With Narcolepsy

An Open Label Study to Evaluate Long-Term Safety and Tolerability of a Once Nightly Formulation of Sodium Oxybate for Extended-Release Oral Suspension (FT218) and the ability to switch from

cataplexy
somnolence
sodium oxybate
sleepiness
excessive daytime sleepiness
  • 258 views
  • 15 Aug, 2021
  • 5 locations